The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Antibiotic resistance breakers: current approaches and future directions
Open accessAbstract
Infections of antibiotic-resistant pathogens pose an ever-increasing threat to mankind. The investigation of novel approaches for tackling the antimicrobial resistance crisis must be part of any global response to this problem if an untimely reversion to the pre-penicillin era of medicine is to be avoided. One such promising avenue of research involves so-called antibiotic resistance breakers (ARBs), capable of re-sensitising resistant bacteria to antibiotics. Although some ARBs have previously been employed in the clinical setting, such as the β-lactam inhibitors, we posit that the broader field of ARB research can yet yield a greater diversity of more effective therapeutic agents than have been previously achieved. This review introduces the area of ARB research, summarises the current state of ARB development with emphasis on the various major classes of ARBs currently being investigated and their modes of action, and offers a perspective on the future direction of the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Computing in the NISQ era and beyond
Preskill, J. (2018) · Quantum · doi:10.22331/q-2018-08-06-79 · Cited by 8,830
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Biofilms: Microbial Life on Surfaces
Donlan, R. M. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0809.020063 · Cited by 4,145
Silhavy, T. J., Kahne, D., & Walker, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000414 · Cited by 3,798
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Efflux-mediated heavy metal resistance in prokaryotes
Nies, D. H. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00048-2 · Cited by 1,557
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“The latter species possesses the tripartite RND systems MexAB-OprM, MexXY-OprM, MexCD-OprJ and MexEFOprN, which together can extrude fluoroquinolones, tetracycline, chloramphenicol and some β-lactams to achieve a multidrug resistant phenotype (Piddock 2006).”
BackgroundBacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria
Ramos, J. L., Duque, E., Gallegos, M.-T., Godoy, P., Ramos-González, M. I., Rojas, A., Terán, W., & Segura, A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161038 · Cited by 791
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
Bacterial Persister Cell Formation and Dormancy
Wood, T. K., Knabel, S. J., & Kwan, B. W. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02636-13 · Cited by 703
Active Efflux and Diffusion Are Involved in Transport of Pseudomonas aeruginosa Cell-to-Cell Signals
Pearson, J. P., Van Delden, C., & Iglewski, B. H. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1203-1210.1999 · Cited by 631
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Novel classes of antibiotics or more of the same?
Coates, A. R., Halls, G., & Hu, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01250.x · Cited by 598
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides
Doi, Y., & Arakawa, Y. (2007) · Clinical Infectious Diseases · doi:10.1086/518605 · Cited by 571
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 565
Efflux pumps as antimicrobial resistance mechanisms
Poole, K. (2007) · Annals of Medicine · doi:10.1080/07853890701195262 · Cited by 562
Industrial production of β-lactam antibiotics
Elander, R. P. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1274-y · Cited by 559
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Bacterial efflux pump inhibitors from natural sources
Stavri, M., Piddock, L. J. V., & Gibbons, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl460 · Cited by 547
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Metallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505
Role of bacterial efflux pumps in biofilm formation
Alav, I., Sutton, J. M., & Rahman, K. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky042 · Cited by 504
Self-citationShields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Wunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., Cornely, O. A., Solomkin, J., Bhowmick, T., Bishara, J., et al. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0214-1 · Cited by 461
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
Kaatz, G. W., Seo, S. M., & Ruble, C. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1086 · Cited by 413
Multidrug Efflux Pumps in Staphylococcus aureus: an Update
Costa, S. S., Viveiros, M., Amaral, L., & Couto, I. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010059 · Cited by 409
English, A. R., Retsema, J. A., Girard, A. E., Lynch, J. E., & Barth, W. E. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.414 · Cited by 404
Gilbert, P., Collier, P. J., & Brown, M. R. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.1865 · Cited by 403
β-Lactam antibiotic resistance: a current structural perspective
Wilke, M. S., Lovering, A. L., & Strynadka, N. C. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.016 · Cited by 383
Teillant, A., Gandra, S., Barter, D., Morgan, D. J., & Laxminarayan, R. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00270-4 · Cited by 379
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
Antibacterial and resistance modifying activity of
OLUWATUYI, M., KAATZ, G., & GIBBONS, S. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.10.009 · Cited by 362
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Lomovskaya, O., Sun, D., Rubio-Aparicio, D., Nelson, K., Tsivkovski, R., Griffith, D. C., & Dudley, M. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-17 · Cited by 353
Nanoparticle approaches against bacterial infections
Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1282 · Cited by 347
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
Biofilm formation and dispersal in Gram-positive bacteria
Abee, T., Kovács, Á. T., Kuipers, O. P., & van der Veen, S. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.10.016 · Cited by 303
Structural basis for the inhibition of bacterial multidrug exporters
Nakashima, R., Sakurai, K., Yamasaki, S., Hayashi, K., Nagata, C., Hoshino, K., Onodera, Y., Nishino, K., & Yamaguchi, A. (2013) · Nature · doi:10.1038/nature12300 · Cited by 298
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Efflux pumps and drug resistance in Gram-negative bacteria
Ma, D., Cook, D. N., Hearst, J. E., & Nikaido, H. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90654-8 · Cited by 282
Lin, L., Nonejuie, P., Munguia, J., Hollands, A., Olson, J., Dam, Q., Kumaraswamy, M., Rivera, H., Corriden, R., Rohde, M., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.021 · Cited by 278
Sudano Roccaro, A., Blanco, A. R., Giuliano, F., Rusciano, D., & Enea, V. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.1968-1973.2004 · Cited by 263
Improved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates
Stapleton, P. D., Shah, S., Anderson, J. C., Hara, Y., Hamilton-Miller, J. M. T., & Taylor, P. W. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.09.027 · Cited by 252
Penwell, W. F., Shapiro, A. B., Giacobbe, R. A., Gu, R.-F., Gao, N., Thresher, J., McLaughlin, R. E., Huband, M. D., DeJonge, B. L. M., Ehmann, D. E., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04808-14 · Cited by 251
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
Wang, R., Lai, T.-P., Gao, P., Zhang, H., Ho, P.-L., Woo, P. C.-Y., Ma, G., Kao, R. Y.-T., Li, H., & Sun, H. (2018) · Nature Communications · doi:10.1038/s41467-018-02828-6 · Cited by 249
Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus
Khan, I. A., Mirza, Z. M., Kumar, A., Verma, V., & Qazi, G. N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.810-812.2006 · Cited by 248
Hon, W.-C., McKay, G. A., Thompson, P. R., Sweet, R. M., Yang, D. S. C., Wright, G. D., & Berghuis, A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80274-3 · Cited by 241
‘Aerosporin’, an Antibiotic Produced by Bacillus aerosporus Greer
Ainsworth, G. C., Brown, A. M., & Brownlee, G. G. (1947) · Nature · doi:10.1038/160263a0 · Cited by 239
Polyethyleneimine is an effective permeabilizer of Gram negative bacteria
Helander, I. M., Alakomi, H.-L., Latva-Kala, K., & Koski, P. (1997) · Microbiology · doi:10.1099/00221287-143-10-3193 · Cited by 237
Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide
Vaara, M., & Vaara, T. (1983) · Nature · doi:10.1038/303526a0 · Cited by 232
Bohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 226
Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureus
Kaatz, G. W., Moudgal, V. V., Seo, S. M., & Kristiansen, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.719-726.2003 · Cited by 224
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Beta-lactamase inhibitors from laboratory to clinic
Bush, K. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.1.109 · Cited by 212
Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli
Opperman, T. J., Kwasny, S. M., Kim, H.-S., Nguyen, S. T., Houseweart, C., D'Souza, S., Walker, G. C., Peet, N. P., Nikaido, H., & Bowlin, T. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01866-13 · Cited by 202
Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and Dicloxacillin
Sutherland, R., Croydon, E. A. P., & Rolinson, G. N. (1970) · BMJ · doi:10.1136/bmj.4.5733.455 · Cited by 191
Aínsa, J. A., Blokpoel, M. C. J., Otal, I., Young, D. B., De Smet, K. A. L., & Martín, C. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5836-5843.1998 · Cited by 189
Bush, K. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.011 · Cited by 188
Morinaka, A., Tsutsumi, Y., Yamada, M., Suzuki, K., Watanabe, T., Abe, T., Furuuchi, T., Inamura, S., Sakamaki, Y., Mitsuhashi, N., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv166 · Cited by 183
Mena, A., Plasencia, V., García, L. M., Hidalgo, O., Ayestarán, I., Albertí, S., Borrell, N., Pérez, J. L., & Oliver, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00418-06 · Cited by 177
Mahamoud, A., Chevalier, J., Davin-Regli, A., Barbe, J., & Pages, J.-M. (2006) · Current Drug Targets · doi:10.2174/138945006777709557 · Cited by 177
Vargiu, A. V., Ruggerone, P., Opperman, T. J., Nguyen, S. T., & Nikaido, H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03283-14 · Cited by 174
Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy
Pule, C. M., Sampson, S. L., Warren, R. M., Black, P. A., van Helden, P. D., Victor, T. C., & Louw, G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv316 · Cited by 173
Inhibitors of Multidrug Resistant Efflux Systems in Bacteria
Zechini, B., & Versace, I. (2009) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489109787236256 · Cited by 172
Payne, D. J., Cramp, R., Winstanley, D. J., & Knowles, D. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.767 · Cited by 171
Castanheira, M., Huband, M. D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00567-17 · Cited by 170
Pannek, S., Higgins, P. G., Steinke, P., Jonas, D., Akova, M., Bohnert, J. A., Seifert, H., & Kern, W. V. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl081 · Cited by 168
Papp‐Wallace, K. M., Nguyen, N. Q., Jacobs, M. R., Bethel, C. R., Barnes, M. D., Kumar, V., Bajaksouzian, S., Rudin, S. D., Rather, P. N., Bhavsar, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00091 · Cited by 168
Wright, A. J. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.3.290 · Cited by 167
Sun, D., Rubio-Aparicio, D., Nelson, K., Dudley, M. N., & Lomovskaya, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01694-17 · Cited by 166
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Kosikowska, P., & Lesner, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1176149 · Cited by 165
Fujita, M., Shiota, S., Kuroda, T., Hatano, T., Yoshida, T., Mizushima, T., & Tsuchiya, T. (2005) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2005.tb03732.x · Cited by 164
Corbett, D. F., Wise, A., Langley, T., Skinner, K., Trimby, E., Birchall, S., Dorali, A., Sandiford, S. K., Williams, J., Warn, P. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00200-17 · Cited by 148
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147
Antibody–Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections
Mariathasan, S., & Tan, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.008 · Cited by 146
Preoperative Antibiotic Prophylaxis
Wenzel, R. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260509 · Cited by 145
Stachyra, T., Péchereau, M.-C., Bruneau, J., Claudon, M., Frère, J., Miossec, C., Coleman, K., & Black, M. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00568-10 · Cited by 145
Moyá, B., Barceló, I. M., Bhagwat, S., Patel, M. V., Bou, G., Papp‐Wallace, K. M., Bonomo, R. A., & Oliver, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02529-16 · Cited by 145
Weakening Effect of Cell Permeabilizers on Gram-Negative Bacteria Causing Biodeterioration
Alakomi, H.-L., Paananen, A., Suihko, M.-L., Helander, I. M., & Saarela, M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.00142-06 · Cited by 141
Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents
Vaara, M., Fox, J., Loidl, G., Siikanen, O., Apajalahti, J., Hansen, F., Frimodt‐Møller, N., Nagai, J., Takano, M., & Vaara, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00405-08 · Cited by 138
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
Mahmood, H. Y., Jamshidi, S., Sutton, J. M., & Rahman, K. M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160304150522 · Cited by 136
Self-citationCastanheira, M., Rhomberg, P. R., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00711-16 · Cited by 135
New β‐lactam–β‐lactamase inhibitor combinations in clinical development
Shlaes, D. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12010 · Cited by 130
Aronoff, S. C., Jacobs, M. R., Johenning, S., & Yamabe, S. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.580 · Cited by 126
Schumacher, A., Steinke, P., Bohnert, J. A., Akova, M., Jonas, D., & Kern, W. V. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki446 · Cited by 126
A Concise Synthesis of a β-Lactamase Inhibitor
Mangion, I. K., Ruck, R. T., Rivera, N. R., Huffman, M. A., & Shevlin, M. (2011) · Organic Letters · doi:10.1021/ol202195n · Cited by 125
Castanheira, M., Mills, J. C., Costello, S. E., Jones, R. N., & Sader, H. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-15 · Cited by 123
Substrate-activated Zinc Binding of Metallo-β-lactamases
Wommer, S., Rival, S. G., Heinz, U., Galleni, M., Frère, J., Franceschini, N., Amicosante, G., Rasmussen, B. W., Bauer, R., & Adolph, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202467200 · Cited by 120
Helander, I. M., Latva‐Kala, K., & Lounatmaa, K. (1998) · Microbiology · doi:10.1099/00221287-144-2-385 · Cited by 120
Vaara, M., Siikanen, O., Apajalahti, J., Fox, J., Møller, J. K., He, H., Poudyal, A., Li, J., Nation, R. L., & Vaara, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01439-09 · Cited by 119
Crandon, J. L., Schuck, V., Banevicius, M. A., Beaudoin, M., Nichols, W. W., Tanudra, M. A., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00851-12 · Cited by 118
Ofek, I., Cohen, S., Rahmani, R., Kabha, K., Tamarkin, D., Herzig, Y., & Rubinstein, E. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.374 · Cited by 117
Susceptibility of gram-negative bacteria to polymyxin B nonapeptide
Viljanen, P., & Vaara, M. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.6.701 · Cited by 112
Catechin Gallates Inhibit Multidrug Resistance (MDR) inStaphylococcus aureus
Gibbons, S., Moser, E., & Kaatz, G. W. (2004) · Planta Medica · doi:10.1055/s-2004-835860 · Cited by 112
Sader, H. S., Rhomberg, P. R., Flamm, R. K., Jones, R. N., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx050 · Cited by 110
Treatment of Gram-negative bacterial infections by potentiation of antibiotics
Zabawa, T. P., Pucci, M. J., Parr, T. R., & Lister, T. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.005 · Cited by 109
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance
Lee, M. D., Galazzo, J. L., Staley, A. L., Lee, J. C., Warren, M. S., Fuernkranz, H. A., Chamberland, S., Lomovskaya, O., & Miller, G. H. (2001) · Il Farmaco · doi:10.1016/s0014-827x(01)01002-3 · Cited by 108
Metal cofactor requirement of β-lactamase II
Davies, R. B., & Abraham, E. P. (1974) · Biochemical Journal · doi:10.1042/bj1430129 · Cited by 108
Mullin, S., Mani, N., & Grossman, T. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4171-4176.2004 · Cited by 105
Alakomi, H., Puupponen‐Pimiä, R., Aura, A., Helander, I. M., Nohynek, L. J., Oksman‐Caldentey, K., & Saarela, M. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf070190y · Cited by 101
Françoise Van Bambeke, A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg225 · Cited by 101
Pfaller, M. A., Huband, M. D., Mendes, R. E., Flamm, R. K., & Castanheira, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.021 · Cited by 96
Kaatz, G. W. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00220-6 · Cited by 93
Broad-Spectrum Peptide Inhibitors of Aminoglycoside Antibiotic Resistance Enzymes
Boehr, D. D., Draker, K.-A., Koteva, K. K., Bains, M., Hancock, R. E. W., & Wright, G. D. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00026-7 · Cited by 90
Livermore, D. M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt118 · Cited by 90
Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa
Lee, J., Park, Y. K., Chung, E. S., Na, I. Y., & Ko, K. S. (2016) · Scientific Reports · doi:10.1038/srep25543 · Cited by 89
Lee, D. L., Powers, J. P. S., Pflegerl, K., Vasil, M. L., Hancock, R. E. W., & Hodges, R. S. (2004) · Journal of Peptide Research · doi:10.1046/j.1399-3011.2003.00106.x · Cited by 87
Chevalier, J., Atifi, S., Eyraud, A., Mahamoud, A., Barbe, J., & Pagès, J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010911z · Cited by 85
Leflon‐Guibout, V., Speldooren, V., Heym, B., & Nicolas-Chanoine, M.-H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2709-2714.2000 · Cited by 85
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
Sader, H. S., Castanheira, M., Huband, M. D., Jones, R. N., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-17 · Cited by 79
Aptamer-assisted novel technologies for detecting bacterial pathogens
Alizadeh, N., Memar, M. Y., Moaddab, S. R., & Kafil, H. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.011 · Cited by 75
Antimicrobial Activities of Amine- and Guanidine-Functionalized Cholic Acid Derivatives
Li, C., Lewis, M. R., Gilbert, A. B., Noel, M. D., Scoville, D. H., Allman, G. W., & Savage, P. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1347 · Cited by 73
Bush, K., & Page, M. G. P. (2017) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9506-4 · Cited by 73
Rodvold, K. A., Gotfried, M. H., Isaacs, R., O’Donnell, J. P., & Stone, E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01089-18 · Cited by 72
In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics
Melchior, N. H., & Keiding, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.1.29 · Cited by 71
Identification of Essential Oils with Strong Activity against Stationary Phase Borrelia burgdorferi
Feng, J., Shi, W., Judith Miklossy, A., Tauxe, G. M., McMeniman, C. J., & Zhang, Y. (2018) · Antibiotics · doi:10.3390/antibiotics7040089 · Cited by 71
Bryan, L. E., & Kwan, S. Y. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/8.suppl_d.1 · Cited by 70
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku025 · Cited by 70
Shapiro, A. B., Gao, N., Jahić, H., Carter, N., Chen, A., & Miller, A. A. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00113 · Cited by 70
Farnesol, a Potential Efflux Pump Inhibitor in Mycobacterium smegmatis
Jin, J., Zhang, J., Guo, N., Sheng, H., Li, L., Liang, J., Wang, X., Li, Y., Liu, M., Wu, X., et al. (2010) · Molecules · doi:10.3390/molecules15117750 · Cited by 69
McLeod, S. M., Shapiro, A. B., Moussa, S. H., Johnstone, M. R., McLaughlin, R. E., DeJonge, B. L. M., & Miller, A. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01576-17 · Cited by 69
Bush, K. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00243 · Cited by 69
Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus
Costa, S. S., Viveiros, M., Rosato, A. E., Melo‐Cristino, J., & Couto, I. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0572-8 · Cited by 67
NOTA: a potent metallo-β-lactamase inhibitor
Somboro, A. M., Tiwari, D., Bester, L. A., Parboosing, R., Chonco, L., Kruger, H. G., Arvidsson, P. I., Govender, T., Naicker, T., & Essack, S. Y. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku538 · Cited by 64
Stogios, P. J., Spanogiannopoulos, P., Evdokimova, E., Egorova, O., Shakya, T., Todorovic, N., Capretta, A. A., Wright, G. D., & Savchenko, A. V. (2013) · Biochemical Journal · doi:10.1042/bj20130317 · Cited by 60
King, A. M., King, D. T., French, S., Brouillette, É., Asli, A., Alexander, J. A. N., Vuckovic, M., Maiti, S. N., Parr, T. R., Brown, E. D., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00944 · Cited by 60
Nzakizwanayo, J., Scavone, P., Jamshidi, S., Hawthorne, J. A., Pelling, H., Dedi, C., Salvage, J. P., Hind, C. K., Guppy, F. M., Barnes, L.-M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12445-w · Cited by 60
Self-citationCrandon, J. L., & Nicolau, D. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00033-15 · Cited by 57
Bina, X. R., Philippart, J. A., & Bina, J. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn466 · Cited by 56
Rojas, L. J., Taracila, M. A., Papp‐Wallace, K. M., Bethel, C. R., Caselli, E., Romagnoli, C., Winkler, M., Spellberg, B. J., Prati, F., & Bonomo, R. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02641-15 · Cited by 56
Sensitization of Gram-negative bacteria to rifampin and OAK combinations
Jammal, J., Zaknoon, F., Kaneti, G., Goldberg, K., & Mor, A. (2015) · Scientific Reports · doi:10.1038/srep09216 · Cited by 55
Castanheira, M., Mendes, R. E., & Sader, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02369-16 · Cited by 55
Adamson, D. H., Krikstopaityte, V., & Coote, P. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv111 · Cited by 54
Jeon, B., & Zhang, Q. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp067 · Cited by 54
Spyrakis, F., Celenza, G., Marcoccia, F., Santucci, M., Cross, S., Bellio, P., Cendron, L., Perilli, M., & Tondi, D. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00428 · Cited by 53
Johnson, J. W., Gretes, M. C., Goodfellow, V. J., Marrone, L., Heynen, M., Strynadka, N. C. J., & Dmitrienko, G. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9086374 · Cited by 52
Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates
Mohamed, Y. F., Abou-Shleib, H. M., Khalil, A. M., Guink, N. E., & El-Nakeeb, M. A. (2016) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2016.01.007 · Cited by 50
Cyclobutanone Mimics of Penicillins: Effects of Substitution on Conformation and Hemiketal Stability
Johnson, J. W., Evanoff, D. P., Savard, M. E., Lange, G., Ramadhar, T. R., Assoud, A., Taylor, N. J., & Dmitrienko, G. I. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801274m · Cited by 48
On-the-fly QM/MM docking with attracting cavities.
Chaskar, P., Zoete, V., & Röhrig, U. F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00406 · Cited by 46
The Efflux Pump Inhibitor Timcodar Improves the Potency of Antimycobacterial Agents
Grossman, T. H., Shoen, C. M., Jones, S. M., Jones, P. L., Cynamon, M. H., & Locher, C. P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04271-14 · Cited by 46
NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases
Zhang, E., Wang, M., Huang, S.-C., Xu, S.-M., Cui, D.-Y., Bo, Y.-L., Bai, P.-Y., Hua, Y., Xiao, C., & Qin, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.074 · Cited by 46
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
Cain, R. M., Brem, J., Zollman, D., McDonough, M. A., Johnson, R. M., SPENCER, J. M., Makena, A., Abboud, M. I., Cahill, S. T., Lee, S. Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01728 · Cited by 46
Pfeifer, H. J., Greenblatt, D. J., & Koch‐Weser, J. (1976) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197605000-00002 · Cited by 45
Goldstein, E. J. C., Citron, D. M., Tyrrell, K. L., & Merriam, C. V. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02418-12 · Cited by 45
Preston, R. A., Mamikonyan, G., DeGraff, S., Chiou, J., Kemper, C. J., Xu, A. S., Mastim, M. A., Yeole, R. D., Chavan, R. P., Patel, A. M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01484-18 · Cited by 43
Sabet, M., Tarazi, Z., Nolan, T. G., Parkinson, J., Rubio-Aparicio, D., Lomovskaya, O., Dudley, M. N., & Griffith, D. C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-17 · Cited by 42
Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells
Mingeot‐Leclercq, M., Tulkens, P. M., Denamur, S., Vaara, T., & Vaara, M. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.033 · Cited by 41
Plasmid-encoded colistin resistance: mcr-one, two, three and counting
Kluytmans, J. A. J. W. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.31.30588 · Cited by 37
Torres, I. M. S., Bento, E. B., Almeida, L. D. C., de Sá, L. Z. C. M., & Lima, E. M. (2012) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822012000300020 · Cited by 37
Jamshidi, S., Sutton, J. M., & Rahman, K. M. (2017) · ACS Omega · doi:10.1021/acsomega.7b00131 · Cited by 34
Self-citationMorinaka, A., Tsutsumi, Y., Yamada, K., Takayama, Y., Sakakibara, S., Takata, T., Abé, T., Furuuchi, T., Inamura, S., Sakamaki, Y., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02704-15 · Cited by 32
OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria
Livne, L., Epand, R. M., Papahadjopoulos‐Sternberg, B., Epand, R. M., & Mor, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-167809 · Cited by 31
Curving Tuberculosis: Current Trends and Future Needs
Rojano, B., Caminero, J. A., & Hayek, M. (2019) · Annals of Global Health · doi:10.5334/aogh.2415 · Cited by 31
Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA
Lainson, J. C., Daly, S. M., Triplett, K. D., Johnston, S. A., Hall, P. R., & Diehnelt, C. W. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00200 · Cited by 28
Yamada, K., Yanagihara, K., Kaku, N., Harada, Y., Migiyama, Y., Nagaoka, K., Morinaga, Y., Nakamura, S., Imamura, Y., Miyazaki, T., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.05.016 · Cited by 23
Kinetics of Action of a Two-Stage Pro-Inhibitor of Serine β-Lactamases
Tilvawala, R. R., & Pratt, R. F. (2013) · Biochemistry · doi:10.1021/bi400873r · Cited by 13
Multidrug Efflux Pumps and Their Inhibitors Characterized by Computational Modeling
Ramaswamy, V. K., Cacciotto, P., Malloci, G., Ruggerone, P., & Vargiu, A. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_30 · Cited by 12
Vaara, M. (1988) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)83889-9 · Cited by 10
Eliopoulos, G. M., Klimm, K., Ferraro, M. J., & Moellering, R. C. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01968142 · Cited by 7
Lambert, P. A., & Sansom, C. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000417629 · Cited by 3
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions
Ovung, A., & Bhattacharyya, J. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00795-9 · Cited by 563
Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria
Gauba, A., & Rahman, K. M. (2023) · Antibiotics · doi:10.3390/antibiotics12111590 · Cited by 255
Self-citationMountcastle, S. E., Vyas, N., Villapun, V. M., Cox, S. C., Jabbari, S., Sammons, R. L., Shelton, R. M., Walmsley, A. D., & Kuehne, S. A. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00214-7 · Cited by 130
Metadata
- Authors
- Laws, M., Shaaban, A., & Rahman, K. M.
- Venue
- FEMS Microbiology Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-05-31
- Volume
- 43
- Issue
- 5
- Pages
- 490-516
- ISSN
- 0168-6445 (ISSN-L)
- 1574-6976
- OpenAlex
- W2947124107
- Cited by
- 356
- References
- 194
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.